Log In
BCIQ
Print this Print this
 

VRP encoding melanoma-specific tumor antigens

  Manage Alerts
Collapse Summary General Information
Company AlphaVax Inc.
DescriptionVirus-like replicon vector particles (VRP) encoding melanoma-specific tumor antigens
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationMelanoma
Indication DetailsTreat melanoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today